PhD candidate Jenna Rogers, CHDS faculty Jennifer Yeh and Zachary Ward, and colleagues developed a decision-analytic microsimulation model to project lifetime outcomes for children
Read more...News
Equity and Cost-Effectiveness of Semaglutide
CHDS faculty Ankur Pandya and colleagues estimated the cost-effectiveness of semaglutide, along with its impact on health equity, as an obesity treatment for Black and White adults aged 65–70 years
Read more...Robinson Delivers Anne Mills Health Economics Lecture
CHDS deputy director Lisa Robinson addressed the intersection between cost-effectiveness analysis (CEA) and benefit-cost analysis (BCA) in the 2026 Anne Mills Health Economics Lecture
Read more...New HPV Model for Cervical Screening
CHDS faculty Nicole Gastineau Campos and Jane Kim, with colleagues at the National Cancer Institute, developed a new simulation model of how human papillomavirus (HPV) infection
Read more...QALY Estimation in Cervical Cancer Screening
CHDS’s Emily Burger, Jane Kim, and colleagues compared four cervical cancer simulation models from the Cancer Intervention and Surveillance Modeling Network (CISNET) to understand why estimates
Read more...Weighing Trade-Offs in Essential Benefits Package Design
CHDS faculty Stéphane Verguet was senior author on a paper by Boshen Jiao and colleagues that modeled optimization of health interventions to include in an essential benefits package. Published in
Read more...Improving HPV Transmission Models
Jenny Spencer and CHDS colleagues Emily Burger, Nicole Gastineau Campos, Mary Carline Regan, Stephen Sy, Jane Kim, and affiliate Allison Portnoy developed and validated
Read more...Targeting Tuberculosis Intervention
CHDS faculty Nicolas Menzies and colleagues estimated the potential health and economic effects of a one-time intervention to test and treat latent tuberculosis infection in United States
Read more...ApoB-Guided Statin Intensification
CHDS faculty Ankur Pandya and affiliate Jinyi Zhu discussed the cost-effectiveness of using apolipoprotein B (apoB), non–high-density lipoprotein cholesterol (non–HDL-C), or low-density lipoprotein
Read more...CHDS Welcomes Incoming PhD Student
CHDS welcomes incoming student Armand Zimmerman to the Decision Science track of Harvard’s PhD Program in Health Policy beginning Fall, 2026. Zimmerman holds a
Read more...